Provigil (Modafinil) Cost in Nebraska: Prices, Insurance, and Savings in 2026

Modafinil is the generic name for the wake-promoting medication sold under the brand name Provigil (Cephalon, now a Teva subsidiary), a Schedule IV controlled substance approved by the FDA for narcolepsy, obstructive sleep apnea (as an adjunct to primary OSA treatment), and shift work disorder. It is not FDA-approved for general fatigue, jet lag, or cognitive enhancement.

The direct answer

The stable, verifiable facts are these: modafinil has been available as an FDA-approved generic for years, generic versions are required to meet FDA bioequivalence standards against the reference brand, and generic modafinil is reliably far less expensive than brand-name Provigil because generic competition exists, as is generally documented for FDA-approved generic drugs. What is not stable, and what this page cannot responsibly state as fact for "2026 in Nebraska," is a specific cash price at a specific pharmacy, a specific Nebraska Medicaid formulary decision, or a specific insurer's prior-authorization rule, because these change throughout the year and vary by plan, pharmacy chain, and county. Anyone deciding where to fill a modafinil prescription in Nebraska should treat published price ranges as a starting orientation, then confirm the actual number by calling the pharmacy or checking a discount-price tool at the time of fill.

Evidence boundary: what is established, what is plausible, what is not established here

Established, from FDA sources:

• Modafinil (Provigil) is FDA-approved for narcolepsy, obstructive sleep apnea, and shift work disorder, and it is a Schedule IV controlled substance.
• Generic modafinil must meet FDA bioequivalence requirements before approval, which is the regulatory basis for treating generic and brand modafinil as clinically interchangeable at the same dose.
• Compounded modafinil can be legally prepared by a pharmacy operating under Section 503A of the Federal Food, Drug, and Cosmetic Act, which allows state-licensed pharmacies to compound patient-specific preparations from a valid prescription; compounded products are not themselves FDA-approved and have not undergone the same manufacturing and bioequivalence review as a commercial generic (FDA, compounding laws and policies; general FDA compounding guidance).

Plausible but not something this page can confirm as current fact:

• General industry reporting suggests generic modafinil cash prices are commonly well below brand Provigil's list price, and that pharmacy discount cards and cash-pay pricing services can lower the price further at many US pharmacies. Whether that holds at a specific Nebraska pharmacy on a specific date requires a live price check.
• Nebraska Medicaid managed care organizations (the state uses a Heritage Health managed care model) may or may not include modafinil on a given plan's preferred drug list in 2026. We have not verified a current Nebraska Medicaid formulary listing for this article, so any statement about coverage status should be confirmed directly with Nebraska Medicaid or the specific managed care plan before a reader relies on it.
• Commercial insurers commonly require prior authorization and sleep-study documentation for wake-promoting agents, consistent with how insurers typically apply clinical guideline criteria, but the exact tier, copay, and documentation requirements are plan-specific and not something a general article can state accurately for every Nebraska plan.

Not established, and removed from this draft because no reliable source supports a precise figure:

• A specific brand or generic dollar price "as of 2026" for Nebraska pharmacies.
• A specific Nebraska Medicaid coverage determination for 2026.
• Specific insurer copay tier amounts, specific telehealth consultation fees, or a specific percentage figure for how often discount cards beat insurance copays. Earlier drafts of consumer pricing pages sometimes cite a precise national percentage for this; that figure needs to be checked against the actual peer-reviewed source before it is republished, and it should not be presented as a Nebraska-specific statistic in any case.

How modafinil pricing generally works, and why "Nebraska price" is not a fixed number

Brand Provigil and generic modafinil contain the identical active ingredient, and FDA generic approval requires bioequivalence testing, so a genuine price gap between brand and generic is expected and well documented as a general pharmaceutical-market pattern. What is not reliable is naming a single Nebraska cash price for either product, because:

• Retail cash prices differ by pharmacy chain, by whether the pharmacy is a warehouse-club pharmacy versus a standard chain, and by whether the fill uses insurance, a discount card, or straight cash.
• Discount-price and cash-pay programs (for example, pharmacy discount cards or mail-order cost-plus pharmacies) publish prices that change over time and are not Nebraska-specific line items you can look up once and trust for the rest of the year.

The practical implication: before assuming a dollar figure, check the current price at the specific pharmacy you plan to use, and compare it against a discount-price lookup tool and, if you have insurance, your plan's adjudicated price after any deductible.

Nebraska Medicaid and modafinil: verify before you assume

Nebraska Medicaid runs through a Heritage Health managed care structure, meaning coverage decisions are made at the level of the contracted managed care organizations rather than a single statewide fee-for-service list. Whether a specific managed care plan currently covers modafinil, requires prior authorization, or excludes it is a fact that can change and that we have not verified against a current, dated Nebraska Medicaid document for this draft. A Medicaid enrollee who needs modafinil for a diagnosed condition should ask their plan directly (using the number on the Medicaid ID card) whether modafinil is on the current preferred drug list, and if it is excluded, ask about the medical exception or prior authorization appeal process available through that plan.

If modafinil is not covered, a prescriber may discuss whether an alternative wake-promoting agent used for narcolepsy is on the plan's formulary. Any switch between wake-promoting agents is a clinical decision between the patient and prescriber, not something to infer from a cost article, because these drugs differ in mechanism, dosing schedule, and side-effect profile.

Commercial insurance: the general pattern, not a Nebraska-specific promise

Commercial insurers commonly cover generic modafinil for its FDA-approved indications and commonly require prior authorization, often including documentation such as a sleep study confirming narcolepsy or obstructive sleep apnea, or evidence of a qualifying shift-work schedule. Off-label use for general fatigue or cognitive enhancement is not an FDA-approved indication and is a common reason for a denial. Beyond that general pattern, the specific tier placement, copay amount, and documentation checklist depend on the individual plan and, if the employer uses a separate pharmacy benefit manager, on that PBM's formulary rather than the medical plan's rules. The fastest way to get an accurate answer for a specific Nebraska plan is to call the number on the pharmacy benefit card and ask for the current formulary tier and prior-authorization criteria for modafinil.

Compounded modafinil: legal pathway, different regulatory status

A pharmacy licensed under Section 503A can legally compound modafinil for an individual patient with a valid prescription, and Nebraska's Board of Pharmacy licenses and regulates pharmacies operating in the state. This is a real, federally described pathway, not an off-the-books workaround. It is also a materially different regulatory category from a commercially manufactured generic: a compounded preparation has not gone through FDA's generic approval and bioequivalence process, and FDA guidance is explicit that compounding is meant to address a medical need a commercial product cannot meet, not simply to serve as a lower-cost alternative. Anyone offered compounded modafinil through a telehealth platform should confirm the dispensing pharmacy's 503A license and its authorization to ship into Nebraska, and should understand that compounded products are rarely covered by commercial insurance.

Telehealth prescribing

Telehealth prescribing of Schedule IV controlled substances, including modafinil, is generally permitted when the prescriber holds an active license (or an interstate compact credential) covering the state where the patient is located and establishes a valid provider-patient relationship consistent with state and federal telehealth rules. Federal controlled-substance telehealth rules have been in flux at various points; a reader relying on telehealth access for a Schedule IV medication should confirm the platform's current licensing and compliance status directly rather than relying on a general article, since federal telehealth prescribing flexibilities for controlled substances have been extended and modified multiple times.

Discount programs and lower-cost pathways worth asking about

Pharmacy discount-card services (for example, GoodRx-type platforms) and mail-order cost-plus pharmacy models are established, real options in the US retail pharmacy market and commonly apply to generic modafinil. Manufacturer copay assistance for brand Provigil, where it exists, typically excludes cash-pay, Medicare, and Medicaid patients, which is standard for manufacturer copay card programs generally. None of these programs' current prices are something this article can state as a fixed number for 2026; they should be checked at the time of fill.

Pharmacology and dosing basics (not individualized dosing advice)

The standard adult dose described in FDA labeling is 200 mg taken once daily, in the morning for narcolepsy and obstructive sleep apnea, or about an hour before a shift for shift work disorder; doses above 200 mg have not been shown to add benefit in the trials that supported approval. Modafinil's exact mechanism is not fully characterized; the leading hypothesis involves dopamine transporter inhibition and increased extracellular dopamine, and it appears to have a different, generally lower abuse-potential profile than amphetamine-type stimulants, though it remains Schedule IV. Reported adverse effects in the FDA label include headache, nausea, and anxiety, and rare but serious skin reactions have been described in postmarketing reports; the exact frequency figures sometimes cited for these effects should be checked against the current FDA label rather than assumed from a secondary source. Modafinil induces CYP3A4 and can reduce the effectiveness of hormonal contraceptives, a labeled interaction that prescribers commonly address by recommending a backup contraceptive method during and after treatment. This section is general background, not individualized dosing guidance; dosing decisions belong to the prescriber managing a specific patient.

When to seek urgent care: severe rash, blistering, mouth sores, chest pain, or signs of a serious allergic reaction after starting modafinil warrant immediate medical attention rather than a wait-and-see approach.

Verification checklist: stable facts vs. facts you must confirm before paying or filing a claim

Use this to separate what you can treat as settled background from what changes and needs a same-day check.

If a claim you read anywhere about Nebraska modafinil pricing or coverage does not fall into the "stable" rows above, treat it as needing same-day verification rather than as a fact you can act on immediately.

Practical steps to reduce cost, without assuming a specific number

Start with your insurance formulary and ask directly whether generic modafinil is covered and what documentation prior authorization requires. If you are uninsured, underinsured, or have not met your deductible, compare a live discount-card price and a cost-plus mail-order price at the time you need to fill, since these move independently of each other. If a telehealth platform bundles a prescription with a compounding pharmacy, add up the consultation fee, medication cost, and shipping, and compare that total against the retail generic price with a discount card before choosing that route, since compounded products are usually not insurance-eligible. If your prescriber has indicated that tablet splitting is appropriate for your prescribed dose, ask them directly whether your specific tablet is scored and approved for splitting; this is a prescriber decision, not a self-directed dosing change.

Frequently asked questions

References

• FDA: Human drug compounding laws and policies

This article covers general information about modafinil regulatory status, coverage patterns, and pricing pathways. It does not establish current Nebraska-specific prices, a current Nebraska Medicaid coverage determination, or individualized dosing guidance, and it has not yet received qualified clinical review.